Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome

New England Journal of Medicine

Volumn 322, Issue 22, 1990, Pages 1555-1560

  Solimena, Michele ^a   Folli, Franco ^b   Aparisi, Roxanne ^a   Pozza, Guido ^b   de Camilli, Pietro ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE;

ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; HUMAN; HUMAN CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; STIFF MAN SYNDROME;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; CEREBROSPINAL FLUID; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HUMAN; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; MALE; MUSCLE RIGIDITY; NEURONS; SPASM; SUPPORT, NON-U.S. GOV'T;

EID: 0025362089     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199005313222202     Document Type: Article

References (40)

1. Moersch FP, Woltman HW. Progressive and fluctuating muscular rigidity and spasm (stiff-man syndrome): report of a case and some observations in 13 other cases. Mayo Clin Proc 1956; 31: 421–7.
2. Gordon EE, Januszko DM, Kaufman L. A critical survey of stiff-man syndrome. Am J Med 1967; 42: 582–99
3. Adams RD, Victor M. Principles of neurology. 4th ed. New York: McGraw-Hill, 1989:1169–71.
4. Layzer RB. Cramps and stiffness. In: Rowland LP, ed. Merritt's textbook of neurology. Philadelphia: Lea & Febiger, 1989:731–5
5. Howard FM Jr. A new and effective drug in the treatment of stiff-man syndrome: preliminary report. Mayo Clin Proc 1963; 38: 203–12.
6. Whelan JL. Baclofen in treatment of the “stiff-man” syndrome. Arch Neurol 1980; 37: 600–1.
7. Spehlmann R, Norcross K, Rasmus SC, Schlageter NL. Improvement of stiff-man syndrome with sodium valproate. Neurology 1981; 31: 162–3.
8. Meinck H-M, Ricker K. Long standing “stiff-man” syndrome: a particular form of disseminated inflammatory CNS disease? J Neurol Neurosurg Psychiatry 1987; 50: 1556–7.
9. Guilleminault J, Sigwald J, Castaigne P. Sleep studies and therapeutic trial with L-dopa in a case of stiff man syndrome. Eur Neurol 1973; 10: 89–96.
10. Layzer RB. Stiff-man syndrome — an autoimmune disease? N Engl J Med 1988; 318: 1060–2.
11. Solimena M, Folli F, Morello F, Toso V. De Camilli P. Autoantibodies directed against GABA-ergic synapses in a second case of stiff-man syndrome and epilepsy. In: Berardelli A, Benecke R, Manfredi M, Marsden CD, eds. Motor disturbances II. New York: Academic Press, 1990:416–22.
12. Eisenbarth GS. Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 1986; 314: 1360–8.
13. Solimena M, Folli F. Denis-Donini S, et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and Type I diabetes mellitus. N Engl J Med 1988; 318: 1012–20.
14. Legay F, Henry S, Tappaz M. Evidence for two distinct forms of native glutamic acid decarboxylase in rat brain soluble extract: an immunoblotting study. J Neurochem 1987; 48: 1022–6.
15. De Camilli P, Miller PE, Levitt P, Walter U, Greengard P. Anatomy of cerebellar Purkinje cells in the rat determined by a specific immunohistochemical marker. Neuroscience 1984; 11: 761–817.
16. Bottazzo GF, Gleichmann H. Immunology and diabetes workshops: report of the first international workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia 1986; 29: 125–6.
17. Scherbaum WA, Mirakian R, Pujol-Borrel R, Dean BM, Bottazzo GF. Immunocytochemistry in the study and diagnosis of organ-specific autoimmune diseases. In: Polak JM, Van Nordeen S, eds. Immunocytochemistry: modern methods and applications. 2nd ed. Bristol, England: John Wright, 1986:456–76.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–5.
19. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979; 76: 4350–4.
20. Mehta PD, Patrick BA. Detection of oligoclonal bands in unconcentrated CSF: isoelectric focusing and silver staining. Neurology 1983; 33: 1365–8.
21. Oertel WH, Schmechel DE, Tappaz ML, Kopin IJ. Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigen–antibody complex. Neuroscience 1981; 6: 2689–700.
22. Solimena M, Piccolo G, Martino G, Folli F, Fratino P, De Camilli P. Autoantibodies directed against gabaergic nerve terminals in a patient with idiopathic late-onset cerebellar ataxia and type IB diabetes mellitus. Clin Neuropathol 1988; 7: 211. abstract.
23. Mugnaini E. Oertel WH. An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In: Bjorklund A, Hokfelt T, eds. Handbook of chemical neuroanatomy. Vol. 4. GABA and neuropeptides in the CNS, Part I. Amsterdam: Elsevier Science Publishers, 1985:436–608.
24. Bottazzo GF, Todd I, Mirakian R, Belfiore A, Pujol-Borrell R. organ-specific autoimmunity: a 1986 overview. Immunol Rev 1986; 96: 137–69.
25. Lennon VA, Lambert EH, Whittingham S, Fairbanks V. Autoimmunity in the Lambert-Eaton myasthenic syndrome. Muscle Nerve 1982; 5: S21–S25.
26. Martinelli P, Pazzaglia P. Montagna P, et al. Stiff-man syndrome associated with nocturnal myoclonus and epilepsy. J Neurol Neurosurg Psychiatry 1978; 41: 458—62.
27. Lorish TR, Thorsteinsson G, Howard FM Jr. Stiff-man syndrome updated. Mayo Clin Proc 1989; 64: 629–36.
28. Gottlieb DI, Chang Y-C, Schwob JE. Monoclonal antibodies to glutamic acid decarboxylase. Proc Natl Acad Sci U S A 1986; 83: 8808–12.
29. Wu J-Y, Denner LA, Wei SC, et al. Production and characterization of polyclonal and monoclonal antibodies to rat brain L-glutamate decarboxylase. Brain Res 1986; 373: 1–14.
30. Kaufman DL, McGinnis JF, Krieger NR, Tobin AJ. Brain glutamate decarboxylase cloned in lambda gt-11: fusion protein produces gamma-aminobutyric acid. Science 1986; 232: 1138–40.
31. Hardin JA. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 1986; 29: 457–60.
32. Craft J, Mimori T, Olsen TL, Hardin JA. The U2 small nuclear ribonucleoprotein particle as an autoantigen: analysis with sera from patients with overlay syndromes. J Clin Invest 1988; 81: 1716–24.
33. Williams achéal, Nutt JG, Hare T. Autoimmunity in stiff man syndrome. Lancet 1988; 2: 222.
34. Germain RN. The ins and outs of antigen processing and presentation. Nature 1986; 322: 687–9.
35. Berzofsky JA. Structural basis of antigen recognition by T lymphocytes: implications for vaccines. J Clin Invest 1988; 82: 1811–7.
36. Townsend AR, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986; 44: 959–68.
37. Wong GH, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW. Inducible expression of H-2 and Ia antigens on brain cells. Nature 1984; 310: 688–91.
38. Vicari AM, Folli F, Pozza G, et al. Plasmapheresis in the treatment of stiffman syndrome. N Engl J Med 1989; 320: 1499.
39. Harding AE, Thompson PD, Kocen RS, Batchelor JR, Davey N, Marsden CD. Plasma exchange and immunosuppression in the stiff man syndrome. Lancet 1989; 2: 915.
40. Johnston C, Millward BA, Hoskins P, Leslie RD, Bottazzo GF, Pyke DA. Islet-cell antibodies as predictors of the later development of type 1 (insulin-dependent) diabetes: a study in identical twins. Diabetologia 1989; 32: 382–6.